HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

sodium tetrametaphosphate

RN given refers to metaphosphoric acid, tetra-Na salt

Also Known As:

cyclophos; cyclotetraphosphate; sodium tetrametaphosphate, monohydrate

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Agarwal, Bharat R: 1 article (01/2022)
2.	Bansal, Deepak: 1 article (01/2022)
3.	Bhat, Sunil: 1 article (01/2022)
4.	Danewa, Arun: 1 article (01/2022)
5.	Desai, Dhwanee: 1 article (01/2022)
6.	Dua, Vikas: 1 article (01/2022)
7.	Gunasekaran, Vinod: 1 article (01/2022)
8.	Kalra, Manas: 1 article (01/2022)
9.	Katewa, Satyendra: 1 article (01/2022)
10.	Kharya, Gaurav: 1 article (01/2022)

Related Diseases

1.	steroid-resistant idiopathic Nephrotic syndrome 06/01/2005 - "Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome."
2.	Wounds and Injuries (Trauma) 06/01/2005 - "Patient was managed conservatively with chemotherapy viz Cyclophos phomide, Adriamycin, Vincristin and prednisolone with total healing of the abdominal wound and closure of the fistula. "
3.	Virus Diseases (Viral Diseases) 01/01/2022 - "Key recommendations are: i) A bone marrow biopsy is must to make a diagnosis of AA; ii) Rule out inherited bone marrow failure syndromes (IBMFS), connective tissue disorders, viral infections, paroxysmal nocturnal hemoglobinuria (PNH), drug or heavy metal induced marrow suppression in all cases of AA; iii) Conservative approach to transfusions should be followed, with a target to keep hemoglobin >6 g/dL in children with no co-morbidities; iv) HLA-matched sibling donor HSCT is the preferred choice of treatment for newly diagnosed very severe/ severe AA; v) In absence of HLA-matched family donor, a matched unrelated donor (MUD) transplant or immunosuppressive therapy (IST) should be considered as alternate choice based on physician expertise; vi) Fludarabine, cyclophos-phamide and anti-thymocyte globulin (ATG) based conditioning with cyclosporine and methotrexate as graft versus host disease (GvHD) prophylaxis is the preferred regimen; vii) Horse ATG and cyclosporine are the recommended drugs for IST. "
4.	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/01/2022 - "Key recommendations are: i) A bone marrow biopsy is must to make a diagnosis of AA; ii) Rule out inherited bone marrow failure syndromes (IBMFS), connective tissue disorders, viral infections, paroxysmal nocturnal hemoglobinuria (PNH), drug or heavy metal induced marrow suppression in all cases of AA; iii) Conservative approach to transfusions should be followed, with a target to keep hemoglobin >6 g/dL in children with no co-morbidities; iv) HLA-matched sibling donor HSCT is the preferred choice of treatment for newly diagnosed very severe/ severe AA; v) In absence of HLA-matched family donor, a matched unrelated donor (MUD) transplant or immunosuppressive therapy (IST) should be considered as alternate choice based on physician expertise; vi) Fludarabine, cyclophos-phamide and anti-thymocyte globulin (ATG) based conditioning with cyclosporine and methotrexate as graft versus host disease (GvHD) prophylaxis is the preferred regimen; vii) Horse ATG and cyclosporine are the recommended drugs for IST. "
5.	Graft vs Host Disease (Graft-Versus-Host Disease) 01/01/2022 - "Key recommendations are: i) A bone marrow biopsy is must to make a diagnosis of AA; ii) Rule out inherited bone marrow failure syndromes (IBMFS), connective tissue disorders, viral infections, paroxysmal nocturnal hemoglobinuria (PNH), drug or heavy metal induced marrow suppression in all cases of AA; iii) Conservative approach to transfusions should be followed, with a target to keep hemoglobin >6 g/dL in children with no co-morbidities; iv) HLA-matched sibling donor HSCT is the preferred choice of treatment for newly diagnosed very severe/ severe AA; v) In absence of HLA-matched family donor, a matched unrelated donor (MUD) transplant or immunosuppressive therapy (IST) should be considered as alternate choice based on physician expertise; vi) Fludarabine, cyclophos-phamide and anti-thymocyte globulin (ATG) based conditioning with cyclosporine and methotrexate as graft versus host disease (GvHD) prophylaxis is the preferred regimen; vii) Horse ATG and cyclosporine are the recommended drugs for IST. "

Related Drugs and Biologics

1.	Cyclosporine (Ciclosporin)
2.	Steroids
3.	Heavy Metals
4.	Prednisolone (Predate)
5.	Methotrexate (Mexate)
6.	Hemoglobins (Hemoglobin)
7.	Doxorubicin (Adriamycin)
8.	Antilymphocyte Serum (Anti-Thymocyte Globulin)
9.	fludarabine

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)